上海莼試生物技術(shù)有限公司
   
菜單 Close 公司首頁(yè) 公司介紹 公司動(dòng)態(tài) 產(chǎn)品展廳 證書榮譽(yù) 聯(lián)系方式 在線留言
您當(dāng)前的位置: 網(wǎng)站首頁(yè) > 產(chǎn)品展廳 >抗體 >液泡蛋白分選受體SORCS抗體規(guī)格
產(chǎn)品展廳
液泡蛋白分選受體SORCS抗體規(guī)格
  • 品牌:上海莼試
  • 產(chǎn)地:進(jìn)口、國(guó)產(chǎn)
  • 貨號(hào):CS12346
  • 發(fā)布日期: 2019-02-25
  • 更新日期: 2024-12-31
產(chǎn)品詳請(qǐng)
產(chǎn)地 進(jìn)口、國(guó)產(chǎn)
品牌 上海莼試
保存條件 Store at -20 °C
貨號(hào) CS12346
應(yīng)用范圍 WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
CAS編號(hào)
抗體名 Anti-SORCS1
克隆性
靶點(diǎn) 詳見說明書
適應(yīng)物種 詳見說明書
形態(tài) 詳見說明書
宿主 詳見說明書
亞型 IgG
標(biāo)識(shí)物 詳見說明書
濃度 1mg/1ml%
免疫原 KLH conjugated synthetic peptide derived from human SORCS1

產(chǎn)品訂購(gòu)信息:
英文名稱  Anti-SORCS1 

中文名稱   液泡蛋白分選受體SORCS抗體規(guī)格 

      SorCS 1; SORCS; SORCS-1; SORCS receptor 1; Sortilin related VPS10 domain containing receptor 1; VPS10 domain containing receptor SorCS1; VPS10 domain receptor protein SORCS 1; VPS10 domain receptor protein SORCS; VPS10 domain receptor protein SORCS1; VPS10 domain receptor SorCS; FLJ41758; FLJ43475; FLJ44957; hSorCS; OTTHUMP00000058855; SORC1_HUMAN.


       1mg/1ml

規(guī)   0.2ml/200μg

抗體來源   Rabbit

克隆類型   polyclonal

交叉反應(yīng)   Human, Mouse, Rat, Dog, Pig, Cow, Horse, Sheep 

產(chǎn)品類型   一抗  

研究領(lǐng)域    細(xì)胞生物 神經(jīng)生物學(xué) 細(xì)胞類型標(biāo)志物 Alzheimer's

蛋白分子量  predicted molecular weight: 127kDa

       Lyophilized or Liquid

 KLH conjugated synthetic peptide derived from human SORCS1 

       IgG

純化方法   affinity purified by Protein A

儲(chǔ)    Preservative: 15mM Sodium Azide, Constituents: 1% BSA, 0.01M PBS, pH 7.4

液泡蛋白分選受體SORCS抗體規(guī)格 產(chǎn)品應(yīng)用    WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500

(石蠟切片需做抗原修復(fù)) 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 There are three sorCS genes that have diverse, partially overlapping functions in the central nervous system. In the developing and mature central nervous system, the homologous SorCS1 and SorCS2 genes and the SorCS3 gene are expressed in a combinatorial, non-overlapping pattern. SorCS proteins show homology to the mosaic receptor SorLA and the neurotensin receptor sortilin, based on a common VPS10 domain, which is the hallmark of the SorCS receptor family. SorCS1 is a type 1 receptor containing a VPS10P domain and a leucine-rich domain. Alternative splicing of human SorCS1 results in four isoforms with different cytoplasmic tails and differential expression in tissues. Human SorCS1 is detected in fetal and infant brain and in fetal retina. Alternative splicing of murine SorCS1 also results in four isoforms. Murine isoform 1 is highly expressed in brain and at lower levels in heart, liver and kidney. It is detected in newborn mouse brain and in adult olfactory bulb and cerebral cortex. Murine isoform 2 is highly expressed in liver and at lower levels in heart, brain, kidney and testis.

Function : SorCS1 belongs to the family of VPS10 domain-containing receptors (the name is derived from the yeast vacuolar protein sorting protein-10, which is involved in sorting of carboxy-peptidase Y from the Golgi apparatus to the vacuole). SorCS1 immunoreactivity is widespread in a population of neurons throughout the brain. Two different types of cellular localization were observed. Most SorCS1 immunoreactive neurons exhibit a punctate cytoplasmic staining which extends into the dendrites, whilst occassionally SorCS1 neuronal immunoreactivity is associated with the plasma membrane.

Subcellular Location : Membrane; Single-pass type I membrane protein.

Tissue Specificity : Detected in fetal and infant brain and in fetal retina.

Post-translational modifications : O-glycosylated.

Similarity : Belongs to the VPS10-related sortilin family. SORCS subfamily.

Contains 5 BNR repeats.

Contains 1 PKD domain.

Database links : UniProtKB/Swiss-Prot: Q8WY21.3

肝肉瓊脂培養(yǎng)基250g用于亞鹽還原厭氧孢子的計(jì)數(shù)

L型細(xì)菌高滲鹽增菌培養(yǎng)基 250g 用于L型細(xì)菌增菌培養(yǎng)

LBS 瓊脂 LBS agar

含0.6%酵母浸膏的胰酪胨大豆肉湯(TSB-YE)250g/瓶用于李斯特氏菌的培養(yǎng)incubationmedia含0.6%酵母浸膏的胰酪胨大豆肉湯(TSB-YE)250g/瓶用于李斯特氏菌的培養(yǎng)

瓷珠菌種保存管(20支) 20支/盒 用于菌種保存(瓷珠法)

高滲真菌學(xué)瓊脂250g用于高滲食品中酵母菌和霉菌檢測(cè)

L型細(xì)菌高滲鹽增菌培養(yǎng)基 250(g) incubation media L型細(xì)菌高滲鹽增菌培養(yǎng)基 250(g)

SOB肉湯 SOB Broth 250克 BR

改良Y培養(yǎng)基250用于分離小腸耶爾森氏菌(GB標(biāo)準(zhǔn))incubationmedia改良Y培養(yǎng)基250用于分離小腸耶爾森氏菌(GB標(biāo)準(zhǔn))

PlateCountAgar

溴化十六烷基胺瓊脂250g用于綠膿假單胞菌的分離培養(yǎng)(新藥典)

MH瓊脂(MHA) 250(g) incubation media MH瓊脂(MHA) 250(g)

四酸煌綠增菌液 2X5支 含碘液2ml/支和煌綠1ml/支,2支添加于100mL(023030)中配成TTB

三糖鐵瓊脂培養(yǎng)基TripleSugarIronAgarMedium用于腸桿菌科細(xì)菌的菌的生化反應(yīng)篩選。

PhosphateSalineBuffer,Modified

CL-0215SK-OV-3(人細(xì)胞)5×106cells/瓶×2

APOM Others Human 人 APOM 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

小鼠骨髓基質(zhì)細(xì)胞完全培養(yǎng)基 100mL

PK(15)豬腎上皮細(xì)胞 PK (15) of porcine kidney epithelial cells MEM+10% FBS

IL18BP Protein Human 重組人 IL18BPa 蛋白 (His 標(biāo)簽)

QGY-7703(人細(xì)胞) 5×106cells/瓶×2 7721(7721細(xì)胞)

液泡蛋白分選受體SORCS抗體規(guī)格CL-0212SK-Hep-1(人細(xì)胞)5×106cells/瓶×2

CREG1 Others Mouse 小鼠 CREG / CREG1 人細(xì)胞裂解液 (陽(yáng)性對(duì)照)

人表皮角質(zhì)細(xì)胞-cDNAHEK-acDNA

MCF/Adr細(xì)胞,人癌阿霉素耐藥細(xì)胞株 團(tuán)頭魴尾鰭細(xì)胞,WCF細(xì)胞 骨細(xì)胞Many types of cells包裝:5 × 105次方(1ml)

2V6.11(人胚腎細(xì)胞) 5×106cells/瓶×2

HCF Pellet 人類成纖維細(xì)胞團(tuán)塊 > 1 mio.cells 人海馬趾星形膠質(zhì)細(xì)胞裂解物HA-h L

抗體的生物素化標(biāo)記實(shí)驗(yàn)要點(diǎn):

1. 液泡蛋白分選受體SORCS抗體規(guī)格 如在反應(yīng)混合液中有疊氮鈉或游離氨基存在,會(huì)抑制標(biāo)記反應(yīng)。因此,蛋白質(zhì)在反應(yīng)前要對(duì) 0.1mol/L碳酸氫鈉緩沖液或0.5mol/L硼酸緩沖液充分透析;

2.所用的NHSB及待生物素化蛋白質(zhì)之間的分子比按蛋白質(zhì)表面的ε-氨基的密度會(huì)有所不同,選擇不當(dāng)則影響標(biāo)記的效率,應(yīng)先用幾個(gè)不同的分子比來篩選最適條件;

3.NHSB量過量也是不利的,抗原的結(jié)合位點(diǎn)可能因此被封閉,導(dǎo)致抗體失活;

4.由于抗體的氨基不易接近可能造成生物素化不足,此時(shí)可加入去污劑如 Triton x-100, Tween20等;

5.當(dāng)游離ε-氨基(賴氨酸殘基的氨基)存在于抗體的抗原結(jié)合位點(diǎn)時(shí),或位于酶的催化位點(diǎn)時(shí),生物素化會(huì)降低或損傷抗體蛋白的結(jié)合力或活性;

6.生物素還可能與不同的功能基團(tuán),如羰基、氨基、巰基、異咪唑基及苯酚基,也可與糖基共價(jià)結(jié)合;

7.交聯(lián)反應(yīng)后,應(yīng)充分透析,否則,殘余的生物素會(huì)對(duì)生物素化抗體與親和素的結(jié)合產(chǎn)生競(jìng)爭(zhēng)作用;

8.在細(xì)胞的熒光標(biāo)記實(shí)驗(yàn)中,中和親和素的本底低,但由于鏈霉親和素含有少量正電荷,故對(duì)某些細(xì)胞可導(dǎo)致高本底。

抗體的鑒定:

1液泡蛋白分選受體SORCS抗體規(guī)格 抗體的效價(jià)鑒定:不管是用于診斷還是用于,制備抗體的目的都是要求較高效價(jià)。不同的抗原制備的抗體,要求的效價(jià)不一。鑒定效價(jià)的方法很多,包括有試管凝集反應(yīng),瓊脂擴(kuò)散試驗(yàn),酶聯(lián)免疫吸附試驗(yàn)等。常用的抗原所制備的抗體一般都有約成的鑒定效價(jià)的方法,以資比較。如制備抗抗體的效價(jià),一般就采用瓊脂擴(kuò)散試驗(yàn)來鑒定。

2)抗體的特異性鑒定:抗體的特異性是指與相應(yīng)抗原或近似抗原物質(zhì)的識(shí)別能力??贵w的特異性高,它的識(shí)別能力就強(qiáng)。衡量特異性通常以交叉反應(yīng)率來表示。交叉反應(yīng)率可用競(jìng)爭(zhēng)抑制試驗(yàn)測(cè)定。以不同濃度抗原和近似抗原分別做競(jìng)爭(zhēng)抑制曲線,計(jì)算各自的結(jié)合率,求出各自在IC50時(shí)的濃度,并按公式計(jì)算交叉反應(yīng)率。 

如果所用抗原濃度IC50濃度為pg/,而一些近似抗原物質(zhì)的IC50濃度幾乎是無窮大時(shí),表示這一抗血清與其他抗原物質(zhì)的交叉反應(yīng)率近似為0,即該血清的特異性較好。

3)抗體親和力:是指抗體和抗原結(jié)合的牢固程度。親和力的高低是由抗原分子的大小,抗體分子的結(jié)合位點(diǎn)與抗原決定簇之間立體構(gòu)型的合適度決定的。有助于維持抗原抗體復(fù)合物穩(wěn)定的分子間力有氫鍵,疏水鍵,側(cè)鏈相反電荷基因的庫(kù)侖力,范德華力和空間斥力。親和力常以親和常數(shù)K表示,K的單位是L/mol??贵w親和力的測(cè)定對(duì)抗體的篩選,確定抗體的用途,驗(yàn)證抗體的均一性等均有重要意義。


聯(lián)系方式
手機(jī):13585831301
Q Q:
亚洲精品乱码久久久久久久久久久久,国产精品视频色尤物yw,亚洲AV日韩AV永久无码色欲,亚洲a∨精品永久无码